{"id":"https://openalex.org/W2167301932","doi":"https://doi.org/10.1002/ange.201411728","title":"Eine kurze Durchflusssynthese von Efavirenz","display_name":"Eine kurze Durchflusssynthese von Efavirenz","publication_year":2015,"publication_date":"2015-02-27","ids":{"openalex":"https://openalex.org/W2167301932","doi":"https://doi.org/10.1002/ange.201411728","mag":"2167301932"},"language":"de","primary_location":{"id":"doi:10.1002/ange.201411728","doi":"https://doi.org/10.1002/ange.201411728","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ange.201411728","pdf_url":null,"source":{"id":"https://openalex.org/S4210200754","display_name":"Angewandte Chemie","issn_l":"0044-8249","issn":["0044-8249","0932-2140","1521-3757"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Angewandte Chemie","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089249602","display_name":"Camille A. Correia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092306","display_name":"Max Planck Institute of Colloids and Interfaces","ror":"https://ror.org/00pwgnh47","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210092306"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Camille A. Correia","raw_affiliation_strings":["Abteilung Biomolekulare Systeme, Max-Planck-Institut fu\u0308r Kolloid- und Grenzfla\u0308chenforschung, Am Mu\u0308hlenberg 1, 14476 Potsdam (Deutschland)","Abteilung Biomolekulare Systeme, Max-Planck-Institut f\u00fcr Kolloid- und Grenzfl\u00e4chenforschung, Am M\u00fchlenberg 1, 14476 Potsdam (Deutschland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abteilung Biomolekulare Systeme, Max-Planck-Institut fu\u0308r Kolloid- und Grenzfla\u0308chenforschung, Am Mu\u0308hlenberg 1, 14476 Potsdam (Deutschland)","institution_ids":["https://openalex.org/I4210092306"]},{"raw_affiliation_string":"Abteilung Biomolekulare Systeme, Max-Planck-Institut f\u00fcr Kolloid- und Grenzfl\u00e4chenforschung, Am M\u00fchlenberg 1, 14476 Potsdam (Deutschland)","institution_ids":["https://openalex.org/I4210092306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005050488","display_name":"Kerry M. Gilmore","orcid":"https://orcid.org/0000-0001-9897-6017","observed_orcids":["https://orcid.org/0000-0001-9897-6017"]},"institutions":[{"id":"https://openalex.org/I4210092306","display_name":"Max Planck Institute of Colloids and Interfaces","ror":"https://ror.org/00pwgnh47","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210092306"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kerry Gilmore","raw_affiliation_strings":["Abteilung Biomolekulare Systeme, Max-Planck-Institut fu\u0308r Kolloid- und Grenzfla\u0308chenforschung, Am Mu\u0308hlenberg 1, 14476 Potsdam (Deutschland)","Abteilung Biomolekulare Systeme, Max-Planck-Institut f\u00fcr Kolloid- und Grenzfl\u00e4chenforschung, Am M\u00fchlenberg 1, 14476 Potsdam (Deutschland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abteilung Biomolekulare Systeme, Max-Planck-Institut fu\u0308r Kolloid- und Grenzfla\u0308chenforschung, Am Mu\u0308hlenberg 1, 14476 Potsdam (Deutschland)","institution_ids":["https://openalex.org/I4210092306"]},{"raw_affiliation_string":"Abteilung Biomolekulare Systeme, Max-Planck-Institut f\u00fcr Kolloid- und Grenzfl\u00e4chenforschung, Am M\u00fchlenberg 1, 14476 Potsdam (Deutschland)","institution_ids":["https://openalex.org/I4210092306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004988752","display_name":"D. Tyler McQuade","orcid":"https://orcid.org/0000-0002-9243-8813","observed_orcids":["https://orcid.org/0000-0002-9243-8813"]},"institutions":[{"id":"https://openalex.org/I103163165","display_name":"Florida State University","ror":"https://ror.org/05g3dte14","country_code":"US","type":"education","lineage":["https://openalex.org/I103163165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Tyler McQuade","raw_affiliation_strings":["Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306 (USA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306 (USA)","institution_ids":["https://openalex.org/I103163165"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008512379","display_name":"Peter H. Seeberger","orcid":"https://orcid.org/0000-0003-3394-8466","observed_orcids":["https://orcid.org/0000-0003-3394-8466"]},"institutions":[{"id":"https://openalex.org/I4210092306","display_name":"Max Planck Institute of Colloids and Interfaces","ror":"https://ror.org/00pwgnh47","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210092306"]},{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Peter H. Seeberger","raw_affiliation_strings":["Abteilung Biomolekulare Systeme, Max-Planck-Institut fu\u0308r Kolloid- und Grenzfla\u0308chenforschung, Am Mu\u0308hlenberg 1, 14476 Potsdam (Deutschland)","Institut fu\u0308r Chemie und Biochemie, Freie Universita\u0308t Berlin, Arnimallee 22, 14195 Berlin (Deutschland)","Abteilung Biomolekulare Systeme, Max-Planck-Institut f\u00fcr Kolloid- und Grenzfl\u00e4chenforschung, Am M\u00fchlenberg 1, 14476 Potsdam (Deutschland)","Institut f\u00fcr Chemie und Biochemie, Freie Universit\u00e4t Berlin, Arnimallee 22, 14195 Berlin (Deutschland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abteilung Biomolekulare Systeme, Max-Planck-Institut fu\u0308r Kolloid- und Grenzfla\u0308chenforschung, Am Mu\u0308hlenberg 1, 14476 Potsdam (Deutschland)","institution_ids":["https://openalex.org/I4210092306"]},{"raw_affiliation_string":"Institut fu\u0308r Chemie und Biochemie, Freie Universita\u0308t Berlin, Arnimallee 22, 14195 Berlin (Deutschland)","institution_ids":["https://openalex.org/I75951250"]},{"raw_affiliation_string":"Abteilung Biomolekulare Systeme, Max-Planck-Institut f\u00fcr Kolloid- und Grenzfl\u00e4chenforschung, Am M\u00fchlenberg 1, 14476 Potsdam (Deutschland)","institution_ids":["https://openalex.org/I4210092306"]},{"raw_affiliation_string":"Institut f\u00fcr Chemie und Biochemie, Freie Universit\u00e4t Berlin, Arnimallee 22, 14195 Berlin (Deutschland)","institution_ids":["https://openalex.org/I75951250"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5008512379"],"corresponding_institution_ids":["https://openalex.org/I4210092306","https://openalex.org/I75951250"],"apc_list":{"value":5790,"currency":"USD","value_usd":5790},"apc_paid":null,"fwci":4.1444,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.94146785,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"127","issue":"16","first_page":"5028","last_page":"5032"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5917999744415283,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5917999744415283,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11407","display_name":"Innovative Microfluidic and Catalytic Techniques Innovation","score":0.07000000029802322,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13859","display_name":"Organic Chemistry Synthesis Methods","score":0.03999999910593033,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hiv-antiretroviral-drugs","display_name":"HIV antiretroviral drugs","score":0.75},{"id":"https://openalex.org/keywords/racemic-synthesis","display_name":"racemic synthesis","score":0.6520000100135803},{"id":"https://openalex.org/keywords/aryl-isocyanates","display_name":"aryl isocyanates","score":0.9049999713897705},{"id":"https://openalex.org/keywords/intramolecular-cyclization","display_name":"intramolecular cyclization","score":0.996999979019165},{"id":"https://openalex.org/keywords/carbamate-synthesis","display_name":"carbamate synthesis","score":0.7609999775886536},{"id":"https://openalex.org/keywords/three-step-synthesis","display_name":"three-step synthesis","score":0.5609999895095825},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.375}],"concepts":[{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.7125176787376404},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47820401191711426},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2496742606163025},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.04251992702484131},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.04206767678260803},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.03143423795700073},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ange.201411728","doi":"https://doi.org/10.1002/ange.201411728","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ange.201411728","pdf_url":null,"source":{"id":"https://openalex.org/S4210200754","display_name":"Angewandte Chemie","issn_l":"0044-8249","issn":["0044-8249","0932-2140","1521-3757"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Angewandte Chemie","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4000000059604645,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322434","display_name":"Max-Planck-Gesellschaft","ror":"https://ror.org/01hhn8329"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1965126102","https://openalex.org/W1965262876","https://openalex.org/W1991470393","https://openalex.org/W1999948429","https://openalex.org/W2002012046","https://openalex.org/W2011506929","https://openalex.org/W2013080250","https://openalex.org/W2018605464","https://openalex.org/W2020338350","https://openalex.org/W2039303410","https://openalex.org/W2046505262","https://openalex.org/W2047856561","https://openalex.org/W2049821854","https://openalex.org/W2071108652","https://openalex.org/W2080560949","https://openalex.org/W2080864133","https://openalex.org/W2097958524","https://openalex.org/W2111769894","https://openalex.org/W2112211764","https://openalex.org/W2112739912","https://openalex.org/W2122047846","https://openalex.org/W2133365461","https://openalex.org/W2158783483","https://openalex.org/W2161625034","https://openalex.org/W2321128093","https://openalex.org/W2324378914","https://openalex.org/W2334996443","https://openalex.org/W4245528831"],"related_works":["https://openalex.org/W1983480635","https://openalex.org/W2611866938","https://openalex.org/W7220761573","https://openalex.org/W2369251050","https://openalex.org/W2968059693","https://openalex.org/W6960130571","https://openalex.org/W2615305904","https://openalex.org/W2952342754","https://openalex.org/W2949076918","https://openalex.org/W7166925161"],"abstract_inverted_index":{"Abstract":[0],"Das":[1],"Arzneimittel":[2],"Efavirenz":[3,57],"ist":[4],"wichtig":[5],"f\u00fcr":[6,12],"die":[7,26,65],"Behandlung":[8],"von":[9,14,28,56],"HIV,":[10],"aber":[11],"Millionen":[13],"Menschen":[15],"nicht":[16],"zug\u00e4nglich.":[17],"Hier":[18],"wird":[19],"ein":[20],"neues":[21],"halbkontinuierliches":[22],"Verfahren":[23],"vorgestellt,":[24],"das":[25],"Herstellung":[27],"rac\u2010Efavirenz":[29],"in":[30,58],"45":[31],"%":[32],"Ausbeute":[33],"erm\u00f6glicht.":[34],"Die":[35,61],"optimierte,":[36],"beispielhafte":[37],"Synthese":[38,67],"basiert":[39],"auf":[40],"dem":[41],"effizienten,":[42],"kupferkatalysierten":[43],"Aufbau":[44],"eines":[45],"Arylisocyanats":[46],"und":[47],"einer":[48],"anschlie\u00dfenden":[49],"intramolekularen":[50],"Cyclisierung":[51],"zur":[52],"Einf\u00fchrung":[53],"des":[54],"Carbamatkerns":[55],"einem":[59],"Schritt.":[60],"dreistufige":[62],"Sequenz":[63],"stellt":[64],"k\u00fcrzeste":[66],"dieses":[68],"lebenswichtigen":[69],"Arzneistoffes":[70],"dar.":[71]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}